In the quest for relief from the burning sensation of acid reflux, many Australians have turned to a seemingly benign solution found on the shelves of their local pharmacy. Proton pump inhibitors (PPIs), such as omeprazole and lansoprazole, are widely used medications that promise to quell the discomfort of heartburn by reducing stomach acid. However, a concerning trend has emerged, one that could leave users grappling with an unexpected and unwelcome dependency.
The convenience of over-the-counter availability has made PPIs a go-to remedy for the distressing symptoms of heartburn, including pain and difficulty swallowing. In fact, the use of these drugs is so prevalent that in England alone, there were 73 million NHS prescriptions dispensed in the 2022-23 period. But what many don’t realise is that these pills, while effective in the short term, can lead to a condition known as rebound acid hypersecretion when they try to stop taking them.
Dr Ahmed Abd Elbary, a UK-based GP, has raised the alarm about the addictive nature of PPIs in a social media reel that has garnered over 394,000 views. He explains that upon discontinuation of the medication, the stomach may respond by producing even more acid than before, exacerbating the symptoms of reflux and making it extremely difficult for individuals to cease using the drug. ‘The crazy thing is the rebound is often worse than your initial symptom before you started the PPI,’ Dr Elbary cautions.
This phenomenon is not just a minor inconvenience; it can trap users in a cycle of dependency as they take more of the medication to manage the worsening symptoms, potentially leading to long-term use. And the risks of long-term use are not to be taken lightly. Studies, though limited, suggest that prolonged use of PPIs may increase the risk of osteoporosis by up to 20 per cent due to the drugs’ interference with calcium absorption, which is crucial for maintaining healthy bones.
Moreover, extended use of PPIs has been linked to other nutrient deficiencies, such as vitamin B12, which is essential for healthy blood cells and nerve function. In rarer cases, there’s even a potential increased risk of stomach cancer. These are serious considerations for anyone, especially those who may already be at higher risk for bone density issues and other health concerns.
But PPIs aren’t the only medications that Dr Elbary warns about. He also highlights the difficulties in discontinuing certain antidepressants, like venlafaxine, and sedative medications, such as benzodiazepines (including lorazepam or diazepam), which can lead to severe withdrawal symptoms and dependency.
The message from health professionals is clear: while these medications can be highly effective for treating conditions like acid reflux, anxiety, and insomnia, they should be used with caution and under close medical supervision. It’s crucial to be fully informed about the potential for dependency and the challenges of withdrawal before starting any medication.
Have you or someone you know used PPIs or other over-the-counter medications for acid reflux? What has your experience been like? We’d love to hear your thoughts—share them in the comments below.
Disclaimer: The information in this article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Everyone’s health is unique, so if you have any concerns or questions about your health, it’s always best to consult with a qualified healthcare professional. We encourage you to seek expert guidance before making any medical decisions.
Also read: Big win for health: More prescription medicines to become cheaper
